Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Immune-transcriptome signatures: a novel approach to understanding GvHD & GvT

Sara Deola • 30 Aug 2020
EBMT 2020
General

Sara Deola, MD, PhD, Sidra Medicine, Doha, Qatar, discusses the results of a longitudinal study of immune-transcriptome signatures as a novel approach to understanding graft-versus-host disease (GvHD) and graft-versus-tumor-effect (GVT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Sara Deola

3:35
Role of the microbiome in GvHD
Sara Deola • 1 Oct 2020
10:24
B-T cell interactions in GvHD
Sara Deola • 30 Aug 2020
3:35
Role of the microbiome in GvHD
Sara Deola • 30 Aug 2020

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals